CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Bioorg Med Chem Lett. 2024 Jul 15;107:129779. doi: 10.1016/j.bmcl.2024.129779. Epub 2024 May 9.
Targeted protein degradation is mediated by small molecules that induce or stabilize protein-protein interactions between targets and the ubiquitin-proteasome machinery. Currently, there remains a need to expand the repertoire of viable E3 ligases available for hijacking. Notably, covalent chemistry has been employed to engage a handful of E3 ligases, including DCAF11. Here, we disclose a covalent PROTAC that enables DCAF11-dependent degradation, featuring a cyanoacrylamide warhead. Our findings underscore DCAF11 as an interesting candidate with a capacity to accommodate diverse electrophilic chemistries compatible with targeted protein degradation.
靶向蛋白降解是由小分子介导的,这些小分子诱导或稳定靶标与泛素-蛋白酶体机器之间的蛋白质-蛋白质相互作用。目前,仍然需要扩大可用于劫持的可行 E3 连接酶的范围。值得注意的是,已经采用了共价化学来结合少数几种 E3 连接酶,包括 DCAF11。在这里,我们披露了一种能够实现 DCAF11 依赖性降解的共价 PROTAC,其特征是氰基丙烯酰胺弹头。我们的研究结果强调了 DCAF11 作为一个有趣的候选者,具有容纳与靶向蛋白降解兼容的各种亲电化学的能力。